Taniguchi Hayato, Ohta Souichi, Honzawa Hiroshi, Takahashi Kouhei, Iwashita Masayuki, Abe Takeru, Takeuchi Ichiro
Advanced Critical Care and Emergency Center, Yokohama City University Medical Center, 4-57 Urafunecho, Minamiku, Yokohama, Japan.
Respir Med Case Rep. 2021;33:101383. doi: 10.1016/j.rmcr.2021.101383. Epub 2021 Mar 9.
Computed tomography (CT) is the most reliable method to evaluate the progression of COVID-19 pneumonitis. However, in a pandemic, transportation of critically ill invasively ventilated patients to radiology facilities is challenging, especially for those on extracorporeal membrane oxygenation (ECMO). Notably, lung ultrasound (LUS) is a favored alternative imaging modality due to its ease of use at the point of care, which reduces the infectious risk of exposure and transmission; repeatability; absence of radiation exposure; and low cost. We demonstrated that serial LUS compares favorably with other imaging modalities in terms of usefulness for evaluating lung aeration and recovery in an ECMO-managed COVID-19 patient.
计算机断层扫描（CT）是评估新型冠状病毒肺炎（COVID-19）肺炎进展的最可靠方法。然而，在大流行期间，将重症有创通气患者转运至放射科设施具有挑战性，尤其是对于那些接受体外膜肺氧合（ECMO）治疗的患者。值得注意的是，肺部超声（LUS）是一种备受青睐的替代成像方式，因为它在床旁使用方便，可降低暴露和传播的感染风险；具有可重复性；无辐射暴露；且成本低廉。我们证明，在评估接受ECMO治疗的COVID-19患者的肺通气和恢复情况方面，系列LUS在实用性方面优于其他成像方式。
